[Federal Register Volume 61, Number 88 (Monday, May 6, 1996)]
[Notices]
[Pages 20257-20260]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-11214]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
[Announcement Number 616]
Sexually Transmitted Diseases Faculty Expansion Program
Introduction
The Centers for Disease Control and Prevention (CDC) announces the
expected availability of fiscal year (FY) 1996 funds for a cooperative
agreement program to provide resources to support faculty positions
specializing in sexually transmitted diseases (STD) to schools of
medicine in the United States. The Department of Health and Human
Services (DHHS) is committed to achieving the health promotion and
disease prevention objectives of ``Healthy People 2000,'' a national
activity to reduce morbidity and mortality and improve the quality of
life. This announcement is related to the priority area of STD and HIV
Infection. (For ordering a copy of ``Healthy People 2000,'' see the
section WHERE TO OBTAIN ADDITIONAL INFORMATION.)
Authority
This program is authorized under section 318 of the Public Health
Service Act, 42 U.S.C. 247c-1, as amended. Regulations governing Grants
for STD Research Demonstrations and Public and Professional Education
are codified in Part 51b, Subparts A and F of Title 42, Code of Federal
Regulations.
Smoke-Free Workplace
The CDC strongly encourages all grant recipients to provide a
smoke-free workplace and to promote the non-use of all tobacco
products, and Public Law 103-227, the Pro-Children Act of 1994,
prohibits smoking in certain facilities that receive Federal funds in
which education, library, day care, health care, and early childhood
development services are provided to children.
Eligible Applicants
Competition for these funds is limited to clinical departments of
schools of medicine in the United States where CDC is not currently
funding STD Prevention/Training Centers or where the National
Institutes of Health (NIH) is not currently funding Sexually
Transmitted Diseases Cooperative Research Centers or STD institutional
training programs. The rationale for this limited competition is that
those areas where STD Prevention/Training Centers and NIH STD
Cooperative Research Centers or STD Institutional Training Programs are
located already have expertise in STDs and have established training
and collaborations similar to those described as goals of this
announcement.
Availability of Funds
Approximately $650,000 is expected to be available in FY 1996 to
fund approximately five awards for a 12-month budget period within a 5-
year project period. It is expected that the awards will begin on or
about September 30, 1996. It is estimated that the average award
(including direct and indirect cost) for the first year will be
$130,000, ranging between $120,000 and $140,000. Continuation awards
within the project period will depend on satisfactory progress and the
availability of funds. It is anticipated that the awards for the second
year will be level with those of the first year.
In the third year, CDC will provide 50 percent of the original
award, and the remainder, summing to at least the same level as the
original award, will be provided as a guaranteed salary shared by the
medical school and the collaborating health department. In the fourth
and fifth years, CDC will contribute a maximum of 25 percent of the
original award, with the remainder of the funds documented through a
collaborating effort between the medical school and the health
department (which cannot be reduced below the level of the original
award). Computation of the salary should include cost-of-living and
merit increases, if applicable. In-kind contributions, such as space
and equipment may not be considered in the total program costs. Total
program costs for the purposes of determining contributions consist of
the five items listed under the USE OF FUNDS section.
Use of Funds
Cooperative agreement funds may be used to support:
The salary and benefits of a faculty member,
Travel to three project-related meetings during budget
period,
Supplies necessary for professional training activities,
Not more than $15,000 annually to support relevant
research by faculty member,
Indirect cost.
Funds may not be used to lease space; to provide diagnostic and
treatment facilities or services; or to pay other expenses normally
supported by the applicant or the collaborating health department.
Funds may not be used for renovation of facilities. Federal funds may
not be used to replace training support. The purpose of this
cooperative agreement is to enable the school of medicine to provide
STD training and education by establishing a faculty position in
sexually transmitted diseases in a clinical department and not to
supplant existing sources of funding for a current faculty member.
Any materials developed in whole or in part with CDC funds shall be
subject to a nonexclusive, irrevocable, royalty-free license to the
government to reproduce, translate, publish, or otherwise use and
authorize others to use for government purposes.
Purpose
The general purpose of this cooperative agreement is:
1. To enable the awardee institutions to provide training and
education in STDs by developing a faculty position dedicated to the
area of sexually transmitted diseases in schools of medicine where such
clinical and research expertise does not currently exist.
2. To support the development of linkages between health
departments and medical schools in the area of STD prevention through
jointly appointed staff who strengthen the scientific basis of
programmatic activities by undertaking research, clinical care, and
teaching responsibilities.
Specifically, the recipient supported under the STD Faculty
Expansion Program will be expected to establish a faculty member to
provide to medical students, house staff, and fellows:
1. Preclinical, didactic instruction in the pathogenesis, natural
history, epidemiology, and management of STDs sufficient to produce a
sound educational basis for subsequent clinical instruction, and
2. Clinical instruction in the prevention, diagnosis and treatment
of STDs.
The recipient will establish a faculty member who will also be
expected to:
1. Care for STD patients at one or more clinics supported by the
State or local health department, and
2. Develop STD research programs, preferably in collaboration with
local or state health departments.
[[Page 20258]]
Program Requirements
In conducting activities to achieve the purpose of this program,
the recipient will be responsible for the activities under A.
(Recipient Activities), and CDC will be responsible for the activities
listed under B. (CDC Activities), as listed below:
A. Recipient Activities
1. Establish a full-time faculty position in STDs in a clinical
department (e.g., internal medicine, pediatrics, obstetrics and
gynecology, preventive or community medicine, or family practice) with
the authority and responsibility to carry out the requirements of this
program.
2. Maintain an agreement with a State or local health department
and the medical school for a jointly appointed position that would
include the potential for use of the health department's clinical
facilities by the faculty member for clinical teaching and research in
STDs. The faculty member will be either a permanent, part-time employee
or a contractor of the health department.
3. Based on the experiences of other successful medical school
programs, participating schools are required to modify the medical
school curriculum to include a minimum of 4 hours of lectures on
clinical and epidemiologic aspects of STDs during the 2nd year and a
minimum of 20 hours of lectures and clinical instruction to be required
of all medical students in the 3rd or 4th year. A minimum of 25 hours
of lectures and clinical instruction must be provided for all residents
in primary care specialties. Clinical instruction of medical students
and residents will take place at the health department facility
described in section 2, above.
4. Provide opportunities for the faculty member for research
through the medical school, the health department, or both. Clinical or
prevention-oriented research should be particularly encouraged. The
research involvement of the faculty member requires the approval of
CDC.
5. Structure the faculty position to maximize the likelihood of
long-term financial support after the termination of CDC support.
6. Arrange for semiannual meetings with the CDC project officer
during the first two years and annual meetings during the last three
years of the project period to review progress, observe training, and
review evaluation.
7. Develop and carry out an evaluation of the effectiveness of the
STD Faculty Expansion Program through analysis and interpretation of
data on medical student and resident performance and on the overall
impact on State and local STD prevention goals, and report this data in
appropriate format to CDC.
B. CDC Activities
1. Be available to provide technical assistance to facilitate the
planning and implementation of curriculum changes, the linkages with
local or State health departments, and the clinical or prevention-
oriented research program.
2. Be available to provide assistance in the design of an
evaluation of the effectiveness of the STD Faculty Expansion Program
through analysis and interpretation of data on medical student and
resident performance and the overall impact on state and local STD
prevention goals.
3. Arrange an annual meeting of CDC-supported faculty members to
review accomplishments, discuss any problems and propose modifications.
Evaluation Criteria
The applications will be evaluated according to the following
criteria:
1. The need for faculty expertise in STDs in the school and
geographic area: The strength of the documentation of the need for a
faculty member with clinical and research expertise in STDs expertise
and the STD prevalence or incidence in the area where the medical
school is located. (20 points)
2. The strength of the agreement with the health department: The
quality of the documentation of a commitment from the State or local
health department to provide clinical facilities, part-time employment
and financial support for the faculty member in clinic facilities that
routinely examine and treat a sufficient number of STD clients to
provide adequate training for medical students and members of the house
staff. The degree to which the applicant demonstrates innovative
approaches to the medical school/health department collaboration that
will contribute to locally relevant STD prevention research and
programmatic activities. (20 points)
3. The quality of the assurances to continue support: The extent to
which the department submitting the application demonstrates a
commitment to assuring research opportunities and financial support for
the faculty member during the grant period. (15 points)
4. The commitment to curriculum changes: The extent to which the
applicant documents commitments from the school of medicine to
implement the curriculum changes described under program requirements.
Consideration will be given to those schools which demonstrate the
largest commitment of additional hours for high quality instruction to
the largest percentage of students and residents over the life of the
project. Consideration will also be given to institutions that propose
to collaborate on similar training with other medical schools or
residency training programs in their geographic area. (15 points)
5. Qualifications for faculty member: The quality of the
documentation of proposed qualifications for the faculty member,
including infectious disease training, significant clinical experience
with STDs, evidence of STD research productivity, and training in
public health and/or epidemiology. A description of the selection or
search process, including a proposed timeframe. (15 points)
6. Evaluation plan: The quality of the plan for evaluation of the
effectiveness (cost) and usefulness of the training in terms of
improved services, prevention research, or achievement of prevention
goals. (10 points)
7. Strong commitment and assurances that the faculty position and
the training will be continued after CDC support is diminished and
terminated. (5 points)
8. Budget: The budget will be evaluated for the extent to which it
is reasonable, clearly justified, and consistent with the intended use
of the funds. The level of support will depend on the availability of
funds. (not scored)
Executive Order 12372 Review
Applications are subject to Intergovernmental Review of Federal
Programs as governed by Executive Order (E.O.) 12372. E.O. 12372 sets
up a system for State and local government review of proposed Federal
assistance applications. Applicants should contact their State Single
Point of Contact (SPOC) as early as possible to alert them to the
prospective applications, and receive any necessary instructions on the
State process. For proposed projects serving more than one State, the
applicant is advised to contact the SPOC for each affected State. A
current list of SPOCs is included in the application kit. If SPOCs have
any State process recommendations on applications submitted to CDC,
they should send them to Van Malone, Grants Management Officer, Grants
Management Branch, Procurement and Grants Office, Centers for Disease
Control and Prevention (CDC), 255 East Paces Ferry Road, NE., Room 300,
Mailstop E-14, Atlanta, GA 30305, not later than 60 days after due date
for receipt of applications. The Program Announcement Number and
Program Title should be referenced on the
[[Page 20259]]
document. CDC does not guarantee to ``accommodate or explain'' State
process recommendations it receives after that date.
Public Health System Reporting Requirements
This program is subject to the Public Health System Reporting
Requirements. Under these requirements, all community-based
nongovernmental applicants must prepare and submit the items identified
below to the head of the appropriate State and/or local health
agency(s) in the program area(s) that may be impacted by the proposed
project no later than the receipt date of the Federal application. The
appropriate State and/or local health agency is determined by the
applicant. The following must be provided:
A. A copy of the face page of the application (SF424).
B. A summary of the project that should be titled ``Public Health
System Impact Statement'' (PHSIS), not to exceed one page, and include
the following:
1. A description of the population to be served;
2. A summary of the services to be provided; and
3. A description of the coordination plans with the appropriate
State and/or local health agencies.
If the State and/or local health official should desire a copy of
the entire application, it may be obtained from the State Single Point
of Contact (SPOC) or directly from the applicant.
Catalog of Federal Domestic Assistance Number
The Catalog of Federal Domestic Assistance Numbers are 93.978,
Sexually Transmitted Disease Research, Demonstrations, and Public
Information and Education Grants, and 93.941, HIV Demonstration,
Research, Public and Professional Education Projects.
Other Requirements
Paperwork Reduction Act
Projects that involve the collection of information from 10 or more
individuals and funded by the cooperative agreement will be subject to
review by the Office of Management and Budget (OMB) under the Paperwork
Reduction Act.
Confidentiality
Applicants must have in place systems to ensure the confidentiality
of patient records.
Human Subjects
If the proposed project involves research on human subjects, the
applicant must comply with the Department of Health and Human Services
Regulations, 45 CFR Part 46, regarding the protection of human
subjects. Assurance must be provided to demonstrate that the project
will be subject to initial and continuing review by an appropriate
institutional review committee. The applicant will be responsible for
providing assurance in accordance with the appropriate guidelines and
form provided in the application kit.
Women, Racial and Ethnic Minorities
It is the policy of the Centers for Disease Control and Prevention
(CDC) and the Agency for Toxic Substances and Disease Registry (ATSDR)
to ensure that individuals of both sexes and the various racial and
ethnic groups will be included in CDC/ATSDR-supported research projects
involving human subjects, whenever feasible and appropriate. Racial and
ethnic groups are those defined in OMB Directive No. 15 and include
American Indian, Alaskan Native, Asian, Pacific Islander, Black and
Hispanic. Applicants shall ensure that women, racial and ethnic
minority populations are appropriately represented in applications for
research involving human subjects. Where clear and compelling rationale
exist that inclusion is inappropriate or not feasible, this situation
must be explained as part of the application. This policy does not
apply to research studies when the investigator cannot control the
race, ethnicity and/or sex of the subjects. Further guidance to this
policy is contained in the Federal Register, Vol. 60, No. 179, pages
47947-47951, and dated Friday, September 15, 1995.
HIV/AIDS Requirements
Recipients must comply with the document entitled, Content of AIDS-
Related Written Materials, Pictorials, Audiovisuals, Questionnaires,
Survey Instruments, and Educational Sessions (June 1992) (a copy is in
the application kit). To meet the requirements for a program review
panel, recipients are encouraged to use an existing program review
panel, such as the one created by the State health department's HIV/
AIDS Prevention Program. If the recipient forms its own program review
panel, at least one member must also be an employee (or a designated
representative) of a State or local health department. The names of the
review panel members must be listed on the Assurance of Compliance form
CDC 0.1113, which is also included in the application kit. The
recipient must submit the program review panel's report that indicates
all materials have been reviewed and approved.
Before funds can be used to develop HIV/AIDS-related materials,
determine whether suitable materials are already available at the CDC
National AIDS Clearinghouse.
Application Submission and Deadline
Applications lacking required documentation as requested in the
Application Content section of the Program Announcement will be
considered incomplete and returned without review. The original and two
copies of the application PHS Form 5161-1 (OMB Number 0937-0189) and
one electronic copy on disk must be submitted to Van Malone, Grants
Management Officer, Attention: Kimberly Boyd, Grants Management
Specialist, Grants Management Branch, Procurement and Grants Office,
Center for Disease Control and Prevention (CDC), 255 East Paces Ferry
Road, NE., Room 300, Mailstop E-15, Atlanta, GA 30305, on or before
July 1, 1996.
1. Deadline: Applications shall be considered as meeting the
deadline if they are:
A. Received on or before the deadline or
B. Sent on or before the deadline date and received in time for
submission to the independent review committee. (Applicants must
request a legibly dated U.S. Postal Service postmark or obtain a
legibly dated receipt from a commercial carrier or U.S. Postal Service.
Privately metered postmarks will not be acceptable proof of timely
mailing.)
2. Late Applications: Applications that do not meet the criteria in
1.A. or 1.B. are considered late applications and will not be
considered in the current competition and will be returned to the
applicant.
Where to Obtain Additional Information
A complete program description, information on application
procedures, an application package, and business management technical
assistance may be obtained from Kimberly Boyd, Grants Management
Specialist, Grants Management Branch, Procurement and Grants Office,
Centers for Disease Control and Prevention (CDC), 255 East Paces Ferry
Road, NE., Room 300, Mailstop E-15, Atlanta, GA 30305, telephone (404)
842-6592, facsimile (404) 842-6513, or via Internet
. Programmatic technical assistance may be
obtained from H. Trent MacKay, M.D., M.P.H., Medical Epidemiologist,
Training and Health Communications
[[Page 20260]]
Branch, Division of STD Prevention, National Center for HIV, STD, and
TB Prevention (NCHSTP), Centers for Disease Control and Prevention
(CDC), 1600 Clifton Road, NE., Mailstop E-02, Atlanta, GA 30333,
telephone (404) 639-8370, facsimile (404) 639-8609, or via Internet
.
Please refer to Announcement 616 ``STD Faculty Expansion Program''
when requesting information or submitting an application.
Potential applicants may obtain a copy of ``Healthy People 2000''
(Full Report: Stock No. 017-001-00474-0) or ``Healthy People 2000''
(Summary Report: Stock No. 017-001-00473-1) referenced in the
INTRODUCTION through the Superintendent of Documents, Government
Printing Office, Washington, DC 20402-9325, telephone (202) 512-1800.
Dated: April 30, 1996.
Joseph R. Carter,
Acting Associate Director for Management and Operations, Centers for
Disease Control and Prevention (CDC).
[FR Doc. 96-11214 Filed 5-3-96; 8:45 am]
BILLING CODE 4163-18-P
